Life Science Company News

Results 1 - 20 out of 500 displayed.

By: GlobenewsWire - 16 May 2022

Related companies: Angion Biomedica Corp.

Valneva Receives Emergency Use Authorization from the United Arab Emirates for its Inactivated COVID-19 Vaccine

By: GlobenewsWire - 16 May 2022

Related companies: Valneva SE

ObsEva to Present at the H.C. Wainwright Global Investment 2022 Conference

By: GlobenewsWire - 16 May 2022

Related companies: ObsEva SA

GeneQuantum Healthcare's Two Next Generation Bioconjugate Drugs, GQ1005 and GQ1007, Have Been Approved for Clinical Trials in Australia

By: PR Newswire Association LLC. - 16 May 2022

Related companies: GeneQuantum Healthcare (Suzhou) Co., Ltd.

Antengene Announces Commercial Availability of XPOVIO® (Selinexor), for the Treatment of Relapsed/Refractory Multiple Myeloma, Prescribed for the First Time Across Mainland China

By: PR Newswire Association LLC. - 16 May 2022

Related companies: Antengene Corporation

Pocared Diagnostics, an Israeli rapid infectious diseases diagnostics leader, secures a EUR 22 million EIB backing for completion of the development and commercialization of its rapid testing system

By: PR Newswire Association LLC. - 16 May 2022

Zenas BioPharma Submits Investigational New Drug Application in China for ZB001 for the Treatment of Thyroid Eye Disease

By: GlobenewsWire - 16 May 2022

Related companies: Zenas BioPharma (USA) LLC

KemPharm Announces Strategic Acquisition of Arimoclomol from Orphazyme, Expanding its Rare CNS Diseases Pipeline

By: GlobenewsWire - 16 May 2022

Related companies: KemPharm, Inc.

UMP Purchases Advanced Medical Imaging Equipment and Facilities

By: PR Newswire Association LLC. - 16 May 2022

Inmagene Receives FDA IND Clearance for a Third Generation BTK Inhibitor Targeting Immunological Diseases

By: PR Newswire Association LLC. - 16 May 2022

Innovent Will Present Clinical Data of IBI110 (anti-LAG-3 monoclonal antibody) and Other Multiple Trials at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

By: PR Newswire Association LLC. - 16 May 2022

Orphazyme A/S under In-Court-Restructuring to sell substantially all of its assets and business activities to KemPharm, Inc.

By: GlobenewsWire - 15 May 2022

Related companies: Orphazyme A/S

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Homology Medicines, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important May 24 Deadline in Securities Class Action - FIXX

By: PR Newswire Association LLC. - 15 May 2022

Related companies: Homology Medicines, Inc.

Avillion announces publication of positive full results from MANDALA Phase III trial of AstraZeneca's PT027 in asthma patients in the New England Journal of Medicine

By: PR Newswire Association LLC. - 15 May 2022

Related companies: Avillion LLP

Boehringer Ingelheim's latest investigational treatment slowed lung function decline in people living with idiopathic pulmonary fibrosis

By: PR Newswire Association LLC. - 15 May 2022

Related companies: Boehringer Ingelheim France SAS | Boehringer Ingelheim (Canada) Ltd

Press Release: Sarclisa® (isatuximab) combination provides unprecedented median progression free survival in patients with relapsed multiple myeloma receiving a proteasome inhibitor therapy

By: GlobenewsWire - 15 May 2022

Related companies: Sanofi

A Dental Practice That Focuses On Easing Dental Anxiety In Singapore

By: PR Newswire Association LLC. - 15 May 2022

Results 1 - 20 out of 500 displayed.

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 »

Enhance your business development with Biotechgate

Click to get started »